Mangalam Drugs And Organics Ltd.

•

mangalamdrugs.comBSE: 532637NSE: MANGALAM

Market Cap₹ 58 Cr.

Current Price

High / Low₹ 78 / 23

Stock P/E—

Book Value₹ 60

Price to Book0.83

Dividend Yield0.00 %

ROCE8.6 %

ROE4.8 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2012 • Bulk Drugs: 100.0%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Working capital cycle has improved - days down from 12 to 8

CONS

Receivables are growing faster than sales - a possible quality concern
Promoter holding has decreased over last 2 years: -14.7pp
Interest coverage is weak at 1.3x - earnings barely cover interest
Company's return on assets is weak at 1.9%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	MANGALAM	36.37	0.00	57.57	0.00	-7.64	44.64	57.12	-0.16	8.55	1.58

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	97	102	76	80	89	73	57	49	58	67	57
	90	91	68	71	80	63	62	52	60	73	64
Operating Profit	7	11	8	9	9	10	-5	-3	-2	-6	-7
OPM %	6.89%	11.18%	10.67%	10.67%	9.72%	13.60%	-8.08%	-6.33%	-2.64%	-8.35%	-12.01%
	0	0	0	0	0	0	0	0	0	0	0
Interest	3	4	4	4	3	4	4	5	4	3	4
Depreciation	4	4	4	4	4	5	4	5	4	5	4
Profit before Tax	0	4	1	1	1	2	-13	-12	-10	-13	-7
Tax %	-1150.00%	10.18%	-362.07%	-124.17%	5.84%	96.34%	-6.15%	41.06%	-0.00%	-1.13%	-13.24%
Net Profit	0	0	3	3	1	0	-14	-7	-10	-13	-8
	0.31	2.23	1.70	1.70	0.81	0.04	-8.72	-4.64	-6.21	-8.48	-4.83

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Mar 2025	TTM
	369	318	232
	351	282	249
Operating Profit	17	36	-17
OPM %	4.71%	11.26%	-7.39%
	0	1	0
Interest	14	15	16
Depreciation	15	17	18
Profit before Tax	-11	5	-42
Tax %	18.08%	-40.43%	9.63%
Net Profit	-9	7	-38
EPS	-5.73	4.25	—
Dividend Payout %	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: -14%
5 Years:: -24%
3 Years:: -30%
1 Year:: -53%

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: —
Last Year:: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Mar 2025
Equity Capital	16	16
	120	133
	96	88
Trade Payables	66	91
	35	38
Total Liabilities	334	366
	148	163
	124	139
	28	39
Cash & Bank	1	3
	33	23
Total Assets	334	366

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Mar 2025
	4	43
Cash from Investing	-12	-19
Cash from Financing	5	-22
	-3	1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	50.31	50.30	50.30	50.30	50.30	50.30	35.64	35.65	35.65
	0.21	0.11	0.11	0.47	0.53	0.11	0.13	0.32	0.11
DIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	49.47	49.58	49.58	49.23	49.16	49.58	64.22	64.02	64.24

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-01

Copy of Newspaper Publication

2026-09-01 - Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-31

Shareholders meeting

2026-08-31 - Mangalam Drugs And Organics Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026

2026-08-17

Fraud/Default/Arrest

2026-08-17 - Mangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/Arrest

2026-08-13

Copy of Newspaper Publication

2026-08-13 - Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-12

Change in Auditors

2026-08-12 - Mangalam Drugs And Organics Limited has informed the Exchange regarding Change in Auditors of the company.

2026-08-12

Change in Auditors

2026-08-12 - Mangalam Drugs And Organics Limited has informed the Exchange regarding Change in Auditors of the company.

2026-08-12

Outcome of Board Meeting

2026-08-12 - Mangalam Drugs And Organics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-06

General Updates

2026-08-06 - Mangalam Drugs And Organics Limited has informed the Exchange about General Updates

2026-07-16

Fraud/Default/Arrest

2026-07-16 - Mangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/Arrest

News

Recent coverage and analyst commentary for MANGALAM

Loading news…

🤖

AI Stock Analyst

Mangalam Drugs And Organics Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

MANGALAM

36.37

0.00

57.57

0.00

-7.64

44.64

57.12

-0.16

8.55

1.58

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

102

Operating Profit

-5

-3

-2

-6

-7

OPM %

6.89%

11.18%

10.67%

9.72%

13.60%

-8.08%

-6.33%

-2.64%

-8.35%

-12.01%

Interest

Depreciation

Profit before Tax

-13

-12

-10

-13

-7

Tax %

-1150.00%

10.18%

-362.07%

-124.17%

5.84%

96.34%

-6.15%

41.06%

-0.00%

-1.13%

-13.24%

Net Profit

-14

-7

-10

-13

-8

0.31

2.23

1.70

0.81

0.04

-8.72

-4.64

-6.21

-8.48

-4.83

Mar 2024

Mar 2025

TTM

369

318

232

351

282

249

Operating Profit

-17

OPM %

4.71%

11.26%

-7.39%

Interest

Depreciation

Profit before Tax

-11

-42

Tax %

18.08%

-40.43%

9.63%

Net Profit

-9

-38

EPS

-5.73

4.25

—

Dividend Payout %

0.00%

—

Mar 2024

Mar 2025

Equity Capital

120

133

Trade Payables

Total Liabilities

334

366

148

163

124

139

Cash & Bank

Total Assets

334

366

Mar 2024

Mar 2025

Cash from Investing

-12

-19

Cash from Financing

-22

-3

Mar 2024

Mar 2025

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

50.31

50.30

35.64

35.65

0.21

0.11

0.47

0.53

0.11

0.13

0.32

0.11

DIIs

0.00

Government

0.00

49.47

49.58

49.23

49.16

49.58

64.22

64.02

64.24

Mangalam Drugs And Organics Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Mangalam Drugs And Organics Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI